{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:37:23Z","timestamp":1787315843232,"version":"build-2736575974"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.aprim.2024.103131","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T09:42:34Z","timestamp":1732700554000},"page":"103131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Actividades preventivas en la mujer. Actualizaci\u00f3n PAPPS 2024"],"prefix":"10.1016","volume":"56","author":[{"given":"Alberto","family":"L\u00f3pez Garc\u00eda-Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Alonso-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pereira Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gonz\u00e1lez Fern\u00e1dez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Romero Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Landa Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2024.103131_bib0600","first-page":"605","article-title":"Preconception Counseling and Care","volume":"108","author":"Close","year":"2023","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.aprim.2024.103131_bib0605","series-title":"Vigilancia epidemiol\u00f3gica de las infecciones de transmisi\u00f3n sexual, 2022. Centro Nacional de Epidemiolog\u00eda, Instituto de Salud Carlos III\/Divisi\u00f3n de Control de VIH, ITS, Hepatitis virales y Tuberculosis.","year":"2024"},{"key":"10.1016\/j.aprim.2024.103131_bib0610","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cen.13731","article-title":"Preconception management of thyroid dysfunction","volume":"89","author":"Okosieme","year":"2018","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.aprim.2024.103131_bib0615","author":"Sackey","year":"2023","journal-title":"The preconception office visit [Internet]"},{"key":"10.1016\/j.aprim.2024.103131_bib0620","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jama.2022.15322","article-title":"Screening for Syphilis Infection in Nonpregnant Adolescents. Adults: US. Preventive Services Task Force Reaffirmation Recommendation Statement","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib0625","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2021.14081","article-title":"Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib0630","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2020.22980","article-title":"Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement","volume":"324","author":"Krist","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib0635","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajog.2012.02.004","article-title":"Environmental exposures: how to counsel preconception and prenatal patients in the clinical setting","volume":"207","author":"Sathyanarayana","year":"2012","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0640","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ogc.2023.03.002","article-title":"Routine Prenatal Care","volume":"50","author":"Peahl","year":"2023","journal-title":"Obstet Gynecol Clin North Am."},{"key":"10.1016\/j.aprim.2024.103131_bib0645","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021347","article-title":"Asymptomatic bacteriuria in pregnancy: systematic reviews of screening and treatment effectiveness and patient preferences","volume":"9","author":"Wingert","year":"2019","journal-title":"BMJ Open."},{"key":"10.1016\/j.aprim.2024.103131_bib0650","first-page":"e261","article-title":"Thyroid Disease in Pregnancy:, ACOG., Practice Bulletin, Number 223","year":"2020","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0655","unstructured":"Grupo de trabajo de la Gu\u00eda de pr\u00e1ctica cl\u00ednica de atenci\u00f3n en el embarazo y puerperio. Gu\u00eda de pr\u00e1ctica cl\u00ednica de atenci\u00f3n en el embarazo y puerperio. Madrid, Espa\u00f1a: Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias de Andaluc\u00eda. Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el SNS: AETSA 2011\/10; 2014."},{"key":"10.1016\/j.aprim.2024.103131_bib0660","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.2021.11922","article-title":"Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib0665","article-title":"Antenatal care","year":"2021","journal-title":"Clinical guideline [NG201]. Published date: March 2008 Last updated:"},{"key":"10.1016\/j.aprim.2024.103131_bib0670","unstructured":"Overview | Hypertension in pregnancy: diagnosis and management | Guidance | NICE. [consultado 1 Jul 2024]. Disponible en: https:\/\/www.nice.org.uk\/guidance\/ng133."},{"issue":"RR\u201310","key":"10.1016\/j.aprim.2024.103131_bib0675","first-page":"1","article-title":"Division of Bacterial Diseases NCfI, Respiratory Diseases CfDC Prevention. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep."},{"key":"10.1016\/j.aprim.2024.103131_bib0680","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.2023.12876","article-title":"Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement","volume":"330","author":"Barry","year":"2023","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib0685","unstructured":"Agencia de Evaluaci\u00f3n de Tecnolog\u00edas Valenciana y Vasca. Revisi\u00f3n espa\u00f1ola sobre los suplementos de Iodo y Ac. F\u00f3lico. Disponible en: http:\/\/www.osakidetza.euskadi.net\/contenidos\/informacion\/publicaciones_informes_estudio\/es_pub\/adjuntos\/Taller_yodo_embarazo_lactancia.pdf."},{"key":"10.1016\/j.aprim.2024.103131_bib0690","unstructured":"[Aesan - Agencia Espa\u00f1ola de Seguridad Alimentaria y Nutrici\u00f3n [Internet]. Gob.es. [consultado 23 Jun 2024]. Disponible en: https:\/\/www.aesan.gob.es\/AECOSAN\/web\/seguridad_alimentaria\/subdetalle\/listeria.htm."},{"issue":"Suppl 1","key":"10.1016\/j.aprim.2024.103131_bib0695","first-page":"102471","article-title":"[Preventive activities in women PAPPS update 2022]","volume":"54","author":"Lopez Garcia-Franco","year":"2022","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2024.103131_bib0700","unstructured":"Interrupci\u00f3n Voluntaria del Embarazo. Datos definitivos correspondientes al a\u00f1o 2022. Ministerio de Sanidad. Disponible en: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/embarazo\/docs\/IVE_2022.pdf."},{"key":"10.1016\/j.aprim.2024.103131_bib0705","year":"2022","journal-title":"Encuesta de anticoncepci\u00f3n en Espa\u00f1a"},{"key":"10.1016\/j.aprim.2024.103131_bib0710","article-title":"Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception","volume":"4","author":"Mack","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0715","series-title":"Criterios m\u00e9dicos de elegibilidad para el uso de anticonceptivos. Resumen ejecutivo","year":"2015"},{"key":"10.1016\/j.aprim.2024.103131_bib0720","article-title":"Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy","volume":"2007","author":"Power","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0725","doi-asserted-by":"crossref","first-page":"115e1","DOI":"10.1016\/j.ajog.2010.04.017","article-title":"The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception","volume":"203","author":"Secura","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0730","series-title":"Faculty of Sexual, Reproductive Healthcare Clinical Guideline Combined Hormonal contraception","year":"2019"},{"key":"10.1016\/j.aprim.2024.103131_bib0735","year":"2016","journal-title":"MMWR U.S. Selected Practice Recommendations for Contraceptive Use [Internet]"},{"key":"10.1016\/j.aprim.2024.103131_bib0740","series-title":"Actualizaci\u00f3n de manejo cl\u00ednico de los anticonceptivos hormonales [Internet].","year":"2005"},{"key":"10.1016\/j.aprim.2024.103131_bib0745","first-page":"227","article-title":"Contraception Recommendations: Updates for the Busy Clinician","volume":"106","author":"Clark","year":"2022","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.aprim.2024.103131_bib0750","series-title":"Family planning: a global handbook for provider, evidence-based guidance developed through worldwide collaboration (internet)","year":"2018"},{"key":"10.1016\/j.aprim.2024.103131_bib0755","doi-asserted-by":"crossref","first-page":"h6712","DOI":"10.1136\/bmj.h6712","article-title":"Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study","volume":"352","author":"Charlton","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2024.103131_bib0760","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"De Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0765","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2024.103131_bib0770","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1016\/j.aprim.2024.103131_bib0775","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/13625187.2017.1372571","article-title":"Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle?","volume":"22","author":"Grandi","year":"2017","journal-title":"Eur J Contracept Reprod Health Care."},{"key":"10.1016\/j.aprim.2024.103131_bib0780","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary Hormonal Contraception and the Risk of Breast Cancer","volume":"377","author":"Morch","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2024.103131_bib0785","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMe1709636","article-title":"Oral Contraceptives and the Small Increased Risk of Breast Cancer","volume":"377","author":"Hunter","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2024.103131_bib0790","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0304-5013(02)75821-4","article-title":"Actualizaci\u00f3n del manejo cl\u00ednico de la anticoncepci\u00f3n intrauterina Recomendaciones de la Conferencia de Consenso","volume":"45","year":"2002","journal-title":"Prog Obste Ginecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0795","series-title":"Emergency Contraception March 2017 [revisado Jul 2023].","year":"2017"},{"key":"10.1016\/j.aprim.2024.103131_bib0800","unstructured":"BOE-A-2002-22188. Ley 41\/2002 de 14 de noviembre, b\u00e1sica reguladora de la autonom\u00eda del paciente y de derechos y obligaciones en materia de informaci\u00f3n y documentaci\u00f3n cl\u00ednica. Disponible en https:\/\/www.boe.es\/eli\/es\/l\/2002\/11\/14\/41\/con."},{"key":"10.1016\/j.aprim.2024.103131_bib0805","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.contraception.2016.08.007","article-title":"Removing medical barriers to contraception - evidence-based recommendations from the Centers for Disease Control and Prevention, 2016","volume":"94","author":"Curtis","year":"2016","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2024.103131_bib0810","article-title":"Immediate postabortal insertion of intrauterine devices","volume":"2014","author":"Okusanya","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0815","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.pec.2021.03.006","article-title":"Latina contraceptive decision-making and use: The importance of provider communication and shared decision-making for patient-centered care","volume":"104","author":"Carvajal","year":"2021","journal-title":"Patient Educ Couns."},{"key":"10.1016\/j.aprim.2024.103131_bib0820","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception."},{"key":"10.1016\/j.aprim.2024.103131_bib0825","author":"Holton","year":"2024","journal-title":"Contraception Clinical overview [internet] Clinicalkey."},{"key":"10.1016\/j.aprim.2024.103131_bib0830","series-title":"How to switch birth control methods","year":"2023"},{"key":"10.1016\/j.aprim.2024.103131_bib0835","unstructured":"World Health Organization. Department of Reproductive Health and Research. Selected practice recommendations for contraceptive use. Third edition 2016. Disponible en https:\/\/www.who.int\/publications\/i\/item\/9789241565400."},{"key":"10.1016\/j.aprim.2024.103131_bib0840","series-title":"Medical eligibility criteria for contraceptive use","article-title":"Reproductive Health and Research.x Improving access to quality care in family planning","year":"2015"},{"issue":"12 Pt 1","key":"10.1016\/j.aprim.2024.103131_bib0845","first-page":"1003","article-title":"National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms","volume":"142","year":"2005","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2024.103131_bib0850","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(24)00462-8","article-title":"Time for a balanced conversation about menopause","volume":"403","year":"2024","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2024.103131_bib0855","first-page":"351","article-title":"A prospective population-based study of menopausal symptoms","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0860","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","volume":"2004","author":"Maclennan","year":"2004","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0865","article-title":"Phytoestrogens for menopausal vasomotor symptoms","volume":"2013","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0870","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0875","series-title":"Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el SNS. Gu\u00eda de trabajo de la Gu\u00eda de Pr\u00e1ctica Cl\u00ednica sobre el abordaje de s\u00edntomas vasomotores, vaginales asociados a la menopausia, postmenopausia","year":"2017"},{"key":"10.1016\/j.aprim.2024.103131_bib0880","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00404-022-06647-5","article-title":"Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review","volume":"307","author":"Goldstajn","year":"2023","journal-title":"Arch Gynecol Obstet."},{"key":"10.1016\/j.aprim.2024.103131_bib0885","first-page":"393","article-title":"Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis","volume":"143","author":"Bonga","year":"2024","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0890","first-page":"737","article-title":"Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial","volume":"141","author":"Neal-Perry","year":"2023","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0895","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib0900","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"2015","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0905","doi-asserted-by":"crossref","first-page":"20631","DOI":"10.1038\/s41598-020-77534-9","article-title":"A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep."},{"key":"10.1016\/j.aprim.2024.103131_bib0910","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2018.06.014","article-title":"Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis","volume":"168","author":"Rovinski","year":"2018","journal-title":"Thromb Res."},{"key":"10.1016\/j.aprim.2024.103131_bib0915","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2024.103131_bib0920","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1350318","article-title":"Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition","volume":"15","author":"Andy","year":"2024","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.aprim.2024.103131_bib0925","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/aje\/152.5.463","article-title":"Relation of demographic and lifestyle factors to symptoms in a multi-racial\/ethnic population of women 40-55 years of age","volume":"152","author":"Gold","year":"2000","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.aprim.2024.103131_bib0930","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinternmed.2010.162","article-title":"An intensive behavioral weight loss intervention and hot flushes in women","volume":"170","author":"Huang","year":"2010","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.aprim.2024.103131_bib0935","article-title":"Exercise for vasomotor menopausal symptoms","volume":"2014","author":"Daley","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0940","first-page":"173","article-title":"The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials","volume":"47","author":"Azizi","year":"2022","journal-title":"Iran J Med Sci."},{"key":"10.1016\/j.aprim.2024.103131_bib0945","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11606-013-2535-9","article-title":"SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials","volume":"29","author":"Shams","year":"2014","journal-title":"J Gen Intern Med."},{"key":"10.1016\/j.aprim.2024.103131_bib0950","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajog.2019.12.011","article-title":"Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis","volume":"222","author":"Shan","year":"2020","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.aprim.2024.103131_bib0955","unstructured":"Menopause: diagnosis and management. NICE guideline [NG23]Published: 12 November 2015 Last updated: 05 December 2019 Overview | Menopause: diagnosis and management | Guidance | NICE."},{"key":"10.1016\/j.aprim.2024.103131_bib0960","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2024.103131_bib0965","series-title":"Symptoms and the menopause. International Position Paper on Women's Health and Menopause: A Comprehensive Approach, 02-3284","author":"Dennerstein","year":"2002"},{"key":"10.1016\/j.aprim.2024.103131_bib0970","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/GME.0000000000002187","article-title":"Menopause hormone therapy and urinary symptoms: a systematic review","volume":"30","author":"Christmas","year":"2023","journal-title":"Menopause."},{"key":"10.1016\/j.aprim.2024.103131_bib0975","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5122(03)00240-8","article-title":"Low-dose (0.3mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis","volume":"47","author":"Marx","year":"2004","journal-title":"Maturitas."},{"key":"10.1016\/j.aprim.2024.103131_bib0980","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00192-020-04397-z","article-title":"Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials","volume":"32","author":"Chen","year":"2021","journal-title":"Int Urogynecol J."},{"key":"10.1016\/j.aprim.2024.103131_bib0985","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(23)02801-5","article-title":"Promoting good mental health over the menopause transition","volume":"403","author":"Brown","year":"2024","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2024.103131_bib0990","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamapsychiatry.2017.3945","article-title":"Should Hormone Therapy Be Used to Prevent Depressive Symptoms During the Menopause Transition?","volume":"75","author":"Joffe","year":"2018","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.aprim.2024.103131_bib0995","first-page":"1","article-title":"Bone density measurement--a systematic review. A report from SBU, the Swedish Council on Technology Assessment in Health Care","volume":"739","year":"1997","journal-title":"J Intern Med Suppl."},{"key":"10.1016\/j.aprim.2024.103131_bib1000","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.berh.2005.06.001","article-title":"Assessment of fracture risk: who should be treated for osteoporosis?","volume":"19","author":"Van der Klift","year":"2005","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.aprim.2024.103131_bib1005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.315.7102.221","article-title":"Bone density and risk of hip fracture in men and women: cross sectional analysis","volume":"315","author":"De Laet","year":"1997","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2024.103131_bib1010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","article-title":"Assessment of fracture risk","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2024.103131_bib1015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-017-4326-3","article-title":"Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study","volume":"29","author":"Rubin","year":"2018","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2024.103131_bib1020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","article-title":"Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial","volume":"391","author":"Shepstone","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2024.103131_bib1025","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/jbmr.3815","article-title":"The Effect of a Screening and Treatment Program for the Prevention of Fractures in Older Women: A Randomized Pragmatic Trial","volume":"34","author":"Merlijn","year":"2019","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.aprim.2024.103131_bib1030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-019-05226-w","article-title":"Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis","volume":"31","author":"Merlijn","year":"2020","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2024.103131_bib1035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2474-13-204","article-title":"FRAX(R) tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort","volume":"13","author":"Azagra","year":"2012","journal-title":"BMC Musculoskelet Disord."},{"key":"10.1016\/j.aprim.2024.103131_bib1040","series-title":"Recomendaciones para la valoraci\u00f3n y tratamiento de la osteoporosis primaria en mujeres de la Comunidad de Madrid","author":"Revilla Abad","year":"2015"},{"key":"10.1016\/j.aprim.2024.103131_bib1045","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-144-11-200606060-00009","article-title":"Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis","volume":"144","author":"Nayak","year":"2006","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/M22-0684","article-title":"Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians","volume":"176","author":"Ayers","year":"2023","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11657-021-01000-w","article-title":"Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes","volume":"16","author":"Lamarre","year":"2021","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.aprim.2024.103131_bib1060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.aprim.2024.103131_bib1065","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/joim.13354","article-title":"Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study","volume":"290","author":"Fu","year":"2021","journal-title":"J Intern Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1070","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab Treatment in Postmenopausal Women with Osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1075","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2024.103131_bib1085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bmj.39435.656250.AD","article-title":"Drugs for pre-osteoporosis: prevention or disease mongering?","volume":"336","author":"Alonso-Coello","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2024.103131_bib1090","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","article-title":"Fracture Prevention with Zoledronate in Older Women with Osteopenia","volume":"379","author":"Reid","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1095","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Curry","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib1100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/GME.0000000000001831","article-title":"Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society","volume":"28","year":"2021","journal-title":"Menopause."},{"key":"10.1016\/j.aprim.2024.103131_bib1105","doi-asserted-by":"crossref","first-page":"E639","DOI":"10.1503\/cmaj.221219","article-title":"Recommendations on screening for primary prevention of fragility fractures","volume":"195","author":"Theriault","year":"2023","journal-title":"CMAJ."},{"key":"10.1016\/j.aprim.2024.103131_bib1110","year":"2017","journal-title":"Clinical guideline Published: 8 August 2012 Last updated:"},{"key":"10.1016\/j.aprim.2024.103131_bib1115","series-title":"Management of osteoporosis and the prevention of fragility fractures","year":"2021"},{"key":"10.1016\/j.aprim.2024.103131_bib1120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"Scientific Advisory Board of the European Society for C Economic Aspects of O, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2024.103131_bib1125","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.aprim.2024.103131_bib1130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1359\/jbmr.081203","article-title":"Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S National Osteoporosis Foundation Guidelines","volume":"24","author":"Donaldson","year":"2009","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.aprim.2024.103131_bib1135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjmed.2007.12.012","article-title":"Association between alcohol consumption and both osteoporotic fracture and bone density","volume":"121","author":"Berg","year":"2008","journal-title":"Am J Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1140","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jbmr.279","article-title":"Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies","volume":"26","author":"Bischoff-Ferrari","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.aprim.2024.103131_bib1145","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2024.103131_bib1150","doi-asserted-by":"crossref","first-page":"h4580","DOI":"10.1136\/bmj.h4580","article-title":"Calcium intake and risk of fracture: systematic review","volume":"351","author":"Bolland","year":"2015","journal-title":"BMJ."},{"key":"10.1016\/j.aprim.2024.103131_bib1155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.aprim.2024.103131_bib1160","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.17789","article-title":"Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis","volume":"2","author":"Yao","year":"2019","journal-title":"JAMA Netw Open."},{"key":"10.1016\/j.aprim.2024.103131_bib1165","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.2018.3185","article-title":"Vitamin D Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib1170","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jama.2021.3069","article-title":"Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib1175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2202106","article-title":"Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults","volume":"387","author":"LeBoff","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2024.103131_bib1180","article-title":"BCGuidelines.ca: Falls: Prevention","year":"2021","journal-title":"Risk Assessment and Management for Community-Dwelling Older Adults"},{"key":"10.1016\/j.aprim.2024.103131_bib1185","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2024.103131_bib1190","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656724002737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656724002737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T09:08:59Z","timestamp":1733216939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656724002737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":119,"alternative-id":["S0212656724002737"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2024.103131","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actividades preventivas en la mujer. Actualizaci\u00f3n PAPPS 2024","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2024.103131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103131"}}